TABLE 3.
Covariates | N | Univariate | Multivariable a | ||
---|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | ||
Age b | 142 | 1.0 (1.0–1.1) | 0.840 | – | – |
Female vs. male | 142 | 2.2 (1.0–5.2) | 0.053 | – | – |
Location (colon vs. rectum) | 142 | 2.5 (1.3–5.0) | 0.008 | 4.2 (1.7–10.6) | 0.002 |
Differentiation (well or moderate vs. poor) | 124 | 1.8 (0.7–4.2) | 0.174 | – | – |
T‐stage (T1‐2 vs. T3‐4) | 142 | 3.8 (1.5–12.8) | 0.013 | 2.8 (0.8–13.5) | 0.152 |
N‐stage (N0 vs. N1‐2) | 142 | 3.5 (1.8–7.0) | <0.001 | 1.4 (0.5–4.0) | 0.547 |
Intra‐ and/or extra‐mural vascular invasion (no/yes) | 113 | 3.3 (1.4–7.1) | 0.004 | 0.7 (0.2–2.3) | 0.589 |
Lymphovascular invasion (no/yes) | 129 | 3.7 (1.8–7.8) | <0.001 | 1.6 (0.6–4.6) | 0.326 |
Perineural invasion (no/yes) | 129 | 3.5 (1.5–7.4) | 0.002 | 2.6 (0.8–7.4) | 0.087 |
Treatment included surgery (no/yes) | 142 | 2.5 (1.3–5.3) | 0.010 | 0.7 (0.1–4.2) | 0.786 |
Methylated BCAT1/IKZF1 detected (no/yes) | 142 | 3.1 (1.4–6.5) | 0.004 | 2.6 (0.9–6.5) | 0.049 |
Abbreviation: HR, hazard ratio.
The multivariable cox proportional hazard regression modeling only included co‐variates identified to be significant in the univariate analysis and cases with missing data were omitted from multivariable analysis (n = 13). In the resulting sub‐population (n = 108), 24 had recurrence.
Analyzed as continuous covariate.